股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年3月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 樂氏國際控股集團有限公司（於開曼群島註冊成立之有限公司） 呈交日期: 2026年4月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01529 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 1,000,000,000 | HKD | | 0.1 HKD | | 100,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 1,000,000,000 | HKD | | 0.1 HKD | | 100,000,000 | 本月底法定/註冊股本 ...

Financial Performance - The group recorded revenue of approximately RMB 343.2 million, an increase of about RMB 87.0 million or approximately 34.0% compared to the previous year[4] - The loss for the year was approximately RMB 24.2 million, a decrease from RMB 30.1 million in the previous year, primarily due to increased revenue from transportation services by approximately RMB 96.2 million[4] - Basic loss per share for the year was approximately RMB 4.19, compared to RMB 17.87 in the previous year[4] - The total operating loss for the year was approximately RMB 23.5 million, compared to RMB 26.2 million in the previous year[6] - The group’s other income, gains, and losses net amount decreased by approximately RMB 10.3 million[4] - The group reported a significant increase in goodwill and intangible assets from RMB 2,158 thousand in 2024 to RMB 3,648 thousand in 2025, an increase of approximately 69%[8] - The company reported a total loss before income tax of RMB 30,142 thousand, primarily driven by unallocated corporate expenses of RMB 35,328 thousand[24] - The group achieved a strong revenue growth of approximately 34.0% year-on-year, reaching about RMB 343.2 million, driven by the recovery of domestic logistics demand in mainland China and strategic resource reallocation in Shanghai and Hangzhou logistics operations[79] Dividends and Shareholder Returns - The group did not recommend the payment of a final dividend for the year, consistent with the previous year[3] - The company does not recommend the payment of any dividends for the fiscal year ending December 31, 2025[58] - The board does not recommend the payment of a final dividend for the year ending December 31, 2025[132] Revenue Breakdown - Total revenue for 2025 was RMB 208,986 thousand, up from RMB 171,105 thousand in 2024, reflecting a growth of about 22%[8] - Revenue from transportation services rose by approximately 55.4% to about RMB 269.9 million, primarily due to additional income from two new subsidiaries established in Hangzhou[90] - Revenue from warehousing services decreased by approximately 46.7% to about RMB 12.8 million, mainly due to the expiration of a warehouse lease in Guangdong[91] - Revenue from in-house logistics services slightly decreased by about 3.3% to approximately RMB 54.9 million[92] - Revenue from sales of traditional Chinese medicine, goat milk powder, and other products amounted to approximately RMB 4.2 million, reflecting the company's strategy to diversify into the health sector[94] Assets and Liabilities - Non-current assets decreased from RMB 85,722 thousand in 2024 to RMB 24,437 thousand in 2025, a decline of approximately 71%[8] - Current liabilities decreased significantly from RMB 110,713 thousand in 2024 to RMB 32,078 thousand in 2025, a reduction of about 71%[10] - The company's total assets decreased from RMB 256,827 thousand in 2024 to RMB 233,423 thousand in 2025, a decline of approximately 9%[10] - The company’s total liabilities decreased from RMB 123,409 thousand in 2024 to RMB 33,327 thousand in 2025, a reduction of about 73%[10] - As of December 31, 2025, the group had net current assets of approximately RMB 176.9 million and cash and cash equivalents of approximately RMB 90.7 million, compared to RMB 60.4 million and RMB 49.7 million respectively in 2024[103] Cost Management - Employee benefit expenses decreased by approximately RMB 11.9 million, while packaging expenses increased by approximately RMB 87.3 million[4] - Employee welfare expenses decreased by approximately 16.6% to about RMB 60.0 million, attributed to the introduction of smart technology and strategic use of outsourced labor[80] - Financing costs decreased sharply to approximately RMB 0.6 million from about RMB 4.0 million last year, mainly due to reduced bank loans and interest expenses after the sale of a subsidiary[100] - Other expenses decreased from approximately RMB 36.3 million in the previous year to about RMB 31.6 million this year, mainly due to increased outsourcing labor costs offset by reductions in hospitality, fleet operating expenses, and legal and professional fees[101] Strategic Developments - The company is primarily engaged in providing transportation, warehousing, in-house logistics, and customized services, along with the sale of Chinese medicine, milk powder, and other products[12] - The group is making significant progress on the Traditional Chinese Medicine logistics industrial park project in Fuzhou, Jiangxi Province, with construction expected to be completed by the end of 2027[81] - The group plans to deepen cooperation within the Traditional Chinese Medicine industry and explore value-added services such as quality traceability and inventory financing[85] - The group aims to implement a shared logistics model to address changing customer demands and enhance operational efficiency without significantly increasing rental space[84] Financial Reporting and Compliance - The consolidated financial statements for the year ending December 31, 2025, will adopt the same accounting policies and methods as those used for the year ending December 31, 2024, with certain amendments as noted[12] - The company has applied the revised Hong Kong Financial Reporting Standards effective from January 1, 2025, which did not have a significant impact on the consolidated financial position and performance[15] - The group’s consolidated financial statements for the year ending December 31, 2025, have been audited and found consistent with the reported amounts[137] - The audit committee has reviewed the consolidated financial statements and confirmed compliance with applicable accounting standards[138] Workforce and Employment - The company employed 524 full-time employees as of December 31, 2025, down from 640 in 2024, indicating a reduction in workforce[125] Future Outlook - The logistics and warehousing industry in China is expected to continue its structural optimization and high-quality development trajectory in 2025[78] - The group anticipates that logistics spending in the Traditional Chinese Medicine sector will reach approximately RMB 11.07 billion by 2026, providing a favorable market backdrop for expansion strategies[85]

（股份代號：1529） （於開曼群島註冊成立的有限公司） 董事會會議通告 香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 的 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部 或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Yues International Holdings Group Limited 樂 氏 國 際 控 股 集 團 有 限 公 司 主席 樂康 香港，2026年3月18日 於 本 公 告 日 期 ， 董 事 會 包 括 四 名 執 行 董 事 樂 康 先 生 、 李 志 剛 先 生 、 劉 萍 女 士 及 樂覺心先生；以及三名獨立非執行董事劉偉彪先生、王軼博士及張耀先生。 承董事會命 樂氏國際控股集團有限公司 樂氏國際控股集團有限公司（「本公司」）董事（「董事」）會（「董事會」）謹此宣佈，董 事會會議將於2026年3月30日（ 星期一 ）舉行，藉以處理（ 其中包括 ）考慮及批准本 公司及其附屬公司截至2025年12月31日止年度之年度業績及其發佈，並考慮派發 末期股 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年2月28日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 樂氏國際控股集團有限公司（於開曼群島註冊成立之有限公司） 呈交日期: 2026年3月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01529 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 1,000,000,000 | HKD | | 0.1 HKD | | 100,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 1,000,000,000 | HKD | | 0.1 HKD | | 100,000,000 | 本月底法 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 樂氏國際控股集團有限公司（於開曼群島註冊成立之有限公司） 呈交日期: 2026年2月2日 FF301 FF301 II. 已發行股份及/或庫存股份變動及足夠公眾持股量的確認 1. 股份分類 普通股 股份類別 不適用 於香港聯交所上市 (註1) 是 證券代號 (如上市) 01529 說明 已發行股份（不包括庫存股份）數目 庫存股份數目 已發行股份總數 上月底結存 667,080,000 0 667,080,000 增加 / 減少 (-) 本月底結存 667,080,000 0 667,080,000 足夠公眾持股量的確認(註4) | 根據《主板上市規則》第13.32D(1)條或第19A.28D(1)條 / 《GEM上市規則》第17.37D(1)條或第25.21D(1)條，我們在此確認，就上述所列股份類別而言，截至本月底: | | --- | | ✔ 已符合適用的公眾持股量要求（見下方） | | 未符合適用的公眾持股量要求（見下方） | | 根 ...

Core Viewpoint - Le Shi International Holdings (01529) has announced a construction agreement for the Jiangxi Le Lao Hao Traditional Chinese Medicine Logistics Industrial Park project, aimed at enhancing the quality of storage services for traditional Chinese medicine products [1] Group 1: Project Details - The construction contract was signed on January 23, 2026, between Jiangxi Le Lao Hao Traditional Chinese Medicine Industry Technology Development Co., Ltd. (the owner) and Fuzhou Chuanghong Construction Engineering Co., Ltd. (the contractor) [1] - The project will be located in the Dongxiang District of Fuzhou City, Jiangxi Province, China, specifically south of Chuangye Avenue and west of Anshi Mingzhu [1] Group 2: Strategic Importance - The logistics industrial park will not only serve the storage and distribution of traditional Chinese medicine but will also support other business segments of the group, including healthcare and wellness [1] - The board believes that this strategic initiative will diversify the company's operations, support long-term development, and enhance shareholder profitability and returns [1]

Core Viewpoint - Le Shi International Holdings (01529.HK) has announced a construction contract for a Traditional Chinese Medicine logistics industrial park in Jiangxi Province, aiming to enhance the quality of storage services for TCM products and support long-term growth and shareholder returns [1]. Group 1 - The company has entered into a construction agreement with Fuzhou Chuanghong Construction Engineering Co., Ltd. for the development of the Jiangxi Le Lao Hao TCM Logistics Industrial Park [1]. - The project will be located in the Dongxiang District of Fuzhou City, Jiangxi Province, specifically south of Chuangye Avenue and west of Anshi Mingzhu [1]. - The logistics industrial park will serve various business segments of the group, including TCM storage, distribution, healthcare, and wellness, thereby expanding market opportunities [1]. Group 2 - The board believes that this strategic initiative will support the diversification of the group's business and enhance long-term development [1]. - The project is expected to improve shareholder profitability and returns through the enhancement of service quality in TCM product logistics [1].

Core Viewpoint - Le Shi International Holdings (01529) has announced a construction agreement for the Jiangxi Le Lao Hao Traditional Chinese Medicine Logistics Industrial Park project, aimed at enhancing the quality of storage services for traditional Chinese medicine products [1] Group 1: Project Details - The construction contract was signed on January 23, 2026, between Jiangxi Le Lao Hao Traditional Chinese Medicine Industry Technology Development Co., Ltd. (the owner) and Fuzhou Chuanghong Construction Engineering Co., Ltd. (the contractor) [1] - The project will be located in the Dongxiang District of Fuzhou City, Jiangxi Province, China, specifically south of Chuangye Avenue and west of Anshi Mingzhu [1] Group 2: Strategic Importance - The logistics industrial park will not only serve the storage and distribution of traditional Chinese medicine but will also support other business segments of the group, including healthcare and wellness [1] - The board believes that this strategic initiative will diversify the company's operations, support long-term development, and enhance shareholder profitability and returns [1]

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 的 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或 任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Yues International Holdings Group Limited 樂 氏 國 際 控 股 集 團 有 限 公 司 （股份代號：1529） （於開曼群島註冊成立的有限公司） 須予披露交易 有關江西樂老號中醫藥物流產業園項目的建築協議 日期： 2026年1月23日 該交易 董 事 會 宣 佈 ， 於 2026 年 1 月 23 日 ， 本 公 司 一 間 間 接 全 資 附 屬 公 司 江 西 樂 老 號 中 醫藥產業科技發展有限公司（「業主」）與撫州市創弘建築工程有限責任公司（「承 包商」）訂立建築合約（「建築協議」），據此，承包商同意就將於中國江西省撫州 市東鄉區創業大道以南、安石明珠以西（「該土地」）興建的江西樂老號中醫藥物 流產業園項目（「該項目」）提供建築服務。 上市規則的涵義 由 於 有 關 該 交 易 的 一 項 ...

Group 1 - The core point of the article is the establishment of a new company, Shanshui Resources (Shenzhen) Co., Ltd., which is fully owned by China Smart Water Industry Group Co., Ltd. [1] - The registered capital of Shanshui Resources is 3 million RMB [1] - The legal representative of the company is Hu Xiong [1] Group 2 - The business scope of Shanshui Resources includes water resource management, sales of daily necessities, wholesale and retail of fresh vegetables and fruits, and various technical services [1] - The company is classified under the wholesale and retail industry, specifically in other wholesale sectors [1] - The company is located at 50 Baguayilu, Pengji Business Time Space Building, Futian District, Shenzhen [1]